Daily

What covid-19 means for the SEC; how to navigate the tax pitfalls of GP-led secondaries; big firms lend a helping hand to their portfolio companies.

A round up of what's going on across private markets; how the PE industry will fare without access to CARES relief.

Deaglo’s founder outlines a one-day risk management strategy for PE firms; IPEV issues guidance on March valuations; even the big players are feeling the pressure on management fees.

A well-balanced succession strategy will be a key differentiating factor in coming through the downturn; GPs using stake-sale profits to capitalize on disruption; Clayton signals he’ll advocate for PE-backed company access to CARES.

Succession planning and the CFO; PEI’s senior editor weighs in on LP liquidity; Pandemic changes the way some will do business in future; Partners Group diverts executive salaries; Update to secondaries law firm database.

LPs report few will decrease commitments; OCIE exam questions on covid-19 revealed; Bain & Co has some guidance for CFOs; 29Bison’s human capital checklist.

LP defaults: happening, but not a trend, for now; Which vintages will suffer?

Mark-to-market’s first crisis, and why it matters; $2trn CARES Act may not include PE-back companies; Jeffries mourns the loss of its CFO.

LP defaults have begun in Europe, and a look at common GP remedies; LPs are reporting high levels of satisfaction with the communication they’re getting from their investment managers; PEI launches CFOs & COOs Forum West.

Covid-19 coverage in one place; Europe Forum dates changed; More NAV considerations; Paul Hastings guidance on LP defaults; FCA filing extension (and SEC); New Jersey flexes its allocation rules; Europe’s Forum date moved; King & Spalding’s covid-19 global regulatory update tracker